Skip to main content
Erschienen in: Acta Neurologica Belgica 2/2017

20.12.2016 | Review

The importance of assessing behaviour and cognition in antiepileptic drug trials in children and adolescents

verfasst von: Lieven Lagae

Erschienen in: Acta Neurologica Belgica | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

It has long been recognised that uncontrolled childhood epilepsy is detrimental to cognition and behaviour, impacting on a patient’s ability to succeed academically. Patients who experience more frequent and serious seizures are at greater risk for cognitive decline, emphasising the need for more effective epilepsy treatments to bring seizures under control. That said, although more effective antiepileptic drugs (AEDs) have the potential to limit the impact of uncontrolled seizures on cognitive and behavioural function, recently it has been acknowledged that deficits in these functions may be caused by AEDs themselves. The cognitive and behavioural effects of older-generation AEDs have been determined largely from AE reporting rather than from specific assessment. Recently, clinical trials of newer-generation AEDs, such as topiramate, levetiracetam and perampanel, have included standardised neuropsychological tests as outcome measures to assess their impact on cognition and behaviour in children and adolescents. However, to understand how we may limit the cognitive and behavioural side effects of AEDs, it is necessary for us to gain a fuller, more accurate, characterisation of their true impact. Such insight will depend on sophisticated and standardised approaches to the design of AED clinical trials. This review provides a general overview of our current understanding of the impact of both epilepsy and AEDs on cognition and behaviour, before focusing on the AEDs for which more detailed assessment, using standardised cognitive and behavioural measures, has been undertaken. We will then go on to discuss the key elements in the design of future AED clinical trials to address current unmet needs.
Literatur
1.
Zurück zum Zitat Lagae L (2006) Cognitive side effects of anti-epileptic drugs: the relevance in childhood epilepsy. Seizure 15:235–241CrossRefPubMed Lagae L (2006) Cognitive side effects of anti-epileptic drugs: the relevance in childhood epilepsy. Seizure 15:235–241CrossRefPubMed
2.
Zurück zum Zitat Williams J, Phillips T, Griebel M, Sharp G, Lange B, Edgar T, Simpson P (2001) Factors associated with academic achievement in children with controlled epilepsy. Epilepsy Behav 2(3):217–223CrossRefPubMed Williams J, Phillips T, Griebel M, Sharp G, Lange B, Edgar T, Simpson P (2001) Factors associated with academic achievement in children with controlled epilepsy. Epilepsy Behav 2(3):217–223CrossRefPubMed
3.
Zurück zum Zitat Boel MJ (2004) Behavioural and neuropsychological problems in refractory paediatric epilepsies. Eur J Paediatr Neurol 8(6):291–297CrossRefPubMed Boel MJ (2004) Behavioural and neuropsychological problems in refractory paediatric epilepsies. Eur J Paediatr Neurol 8(6):291–297CrossRefPubMed
4.
Zurück zum Zitat Bjornaes H, Stabell K, Henriksen O, Loyning Y (2001) The effects of refractory epilepsy on intellectual functioning in children and adults. A longitudinal study. Seizure 10(4):250–259CrossRefPubMed Bjornaes H, Stabell K, Henriksen O, Loyning Y (2001) The effects of refractory epilepsy on intellectual functioning in children and adults. A longitudinal study. Seizure 10(4):250–259CrossRefPubMed
5.
Zurück zum Zitat Braakman HM, Ijff DM, Vaessen MJ, Debeij-van Hall MH, Hofman PA, Backes WH, Vles JS, Aldenkamp AP (2012) Cognitive and behavioural findings in children with frontal lobe epilepsy. Eur J Paediatr Neurol 16(6):707–715CrossRefPubMed Braakman HM, Ijff DM, Vaessen MJ, Debeij-van Hall MH, Hofman PA, Backes WH, Vles JS, Aldenkamp AP (2012) Cognitive and behavioural findings in children with frontal lobe epilepsy. Eur J Paediatr Neurol 16(6):707–715CrossRefPubMed
6.
Zurück zum Zitat Helmstaedter C, Kurthen M, Lux S, Reuber M, Elger C (2003) Chronic epilepsy and cognition: a longitudinal study in temporal lobe epilepsy. Ann Neurol 54(4):425–432CrossRefPubMed Helmstaedter C, Kurthen M, Lux S, Reuber M, Elger C (2003) Chronic epilepsy and cognition: a longitudinal study in temporal lobe epilepsy. Ann Neurol 54(4):425–432CrossRefPubMed
7.
Zurück zum Zitat Gonzalez LM, Embuldeniya US, Harvey AS, Wrennall JA, Testa R, Anderson VA, Wood AG (2014) Developmental stage affects cognition in children with recently-diagnosed symptomatic focal epilepsy. Epilepsy Behav 39:97–104CrossRefPubMed Gonzalez LM, Embuldeniya US, Harvey AS, Wrennall JA, Testa R, Anderson VA, Wood AG (2014) Developmental stage affects cognition in children with recently-diagnosed symptomatic focal epilepsy. Epilepsy Behav 39:97–104CrossRefPubMed
8.
Zurück zum Zitat Ali DB, Tomek M, Lisk DR (2014) The effects of epilepsy on child education in Sierra Leone. Epilepsy Behav 37:236–240CrossRefPubMed Ali DB, Tomek M, Lisk DR (2014) The effects of epilepsy on child education in Sierra Leone. Epilepsy Behav 37:236–240CrossRefPubMed
9.
Zurück zum Zitat Aguiar B, Guerreiro M, McBrian D, Montenegro M (2007) Seizure impact on the school attendance in children with epilepsy. Seizure 16(8):698–702CrossRefPubMed Aguiar B, Guerreiro M, McBrian D, Montenegro M (2007) Seizure impact on the school attendance in children with epilepsy. Seizure 16(8):698–702CrossRefPubMed
10.
Zurück zum Zitat Hunter RM, Reilly C, Atkinson P, Das KB, Gillberg C, Chin RF, Scott RC, Neville BG, Morris S (2015) The health, education, and social care costs of school-aged children with active epilepsy: a population-based study. Epilepsia 56(7):1056–1064CrossRefPubMed Hunter RM, Reilly C, Atkinson P, Das KB, Gillberg C, Chin RF, Scott RC, Neville BG, Morris S (2015) The health, education, and social care costs of school-aged children with active epilepsy: a population-based study. Epilepsia 56(7):1056–1064CrossRefPubMed
11.
Zurück zum Zitat de Kinderen R, Evers S, Rinkens R, Postulart D, Vadar C, Majoie M, Aldenkamp A (2014) Side-effects of antiepileptic drugs: the economic burden. Seizure 23(3):184–190CrossRefPubMed de Kinderen R, Evers S, Rinkens R, Postulart D, Vadar C, Majoie M, Aldenkamp A (2014) Side-effects of antiepileptic drugs: the economic burden. Seizure 23(3):184–190CrossRefPubMed
12.
Zurück zum Zitat French JA, Gazzola DM (2011) New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety. Ther Adv Drug Saf 2(4):141–158CrossRefPubMedCentralPubMed French JA, Gazzola DM (2011) New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety. Ther Adv Drug Saf 2(4):141–158CrossRefPubMedCentralPubMed
14.
Zurück zum Zitat Witt JA, Helmstaedter C (2013) Monitoring the cognitive effects of antiepileptic pharmacotherapy—approaching the individual patient. Epilepsy Behav 26(3):450–456CrossRefPubMed Witt JA, Helmstaedter C (2013) Monitoring the cognitive effects of antiepileptic pharmacotherapy—approaching the individual patient. Epilepsy Behav 26(3):450–456CrossRefPubMed
16.
Zurück zum Zitat Glauser TA (2004) Behavioral and psychiatric adverse events associated with antiepileptic drugs commonly used in pediatric patients. J Child Neurol 19(Suppl. 1):S25–S38CrossRefPubMed Glauser TA (2004) Behavioral and psychiatric adverse events associated with antiepileptic drugs commonly used in pediatric patients. J Child Neurol 19(Suppl. 1):S25–S38CrossRefPubMed
17.
18.
Zurück zum Zitat Sahoo SS, Lhatoo SD, Gupta DK, Cui L, Zhao M, Jayapandian C, Bozorgi A, Zhang GQ (2014) Epilepsy and seizure ontology: towards an epilepsy informatics infrastructure for clinical research and patient care. J Am Med Inform Assoc 21(1):82–89CrossRefPubMed Sahoo SS, Lhatoo SD, Gupta DK, Cui L, Zhao M, Jayapandian C, Bozorgi A, Zhang GQ (2014) Epilepsy and seizure ontology: towards an epilepsy informatics infrastructure for clinical research and patient care. J Am Med Inform Assoc 21(1):82–89CrossRefPubMed
19.
Zurück zum Zitat Meador KJ, Yang H, Pina-Garza JE, Laurenza A, Kumar D, Wesnes KA (2016) Cognitive effects of adjunctive perampanel for partial-onset seizures: a randomized trial. Epilepsia 57(2):243–251CrossRefPubMedCentralPubMed Meador KJ, Yang H, Pina-Garza JE, Laurenza A, Kumar D, Wesnes KA (2016) Cognitive effects of adjunctive perampanel for partial-onset seizures: a randomized trial. Epilepsia 57(2):243–251CrossRefPubMedCentralPubMed
20.
Zurück zum Zitat Wesnes KA (2008) Assessing change in cognitive function in dementia: the relative utilities of the Alzheimer’s Disease Assessment Scale-Cognitive Subscale and the Cognitive Drug Research system. Neurodegener Dis 5(3–4):261–263CrossRefPubMed Wesnes KA (2008) Assessing change in cognitive function in dementia: the relative utilities of the Alzheimer’s Disease Assessment Scale-Cognitive Subscale and the Cognitive Drug Research system. Neurodegener Dis 5(3–4):261–263CrossRefPubMed
21.
Zurück zum Zitat Cochrane HC, Marson AG, Baker GA, Chadwick DW (1998) Neuropsychological outcomes in randomized controlled trials of antiepileptic drugs: a systematic review of methodology and reporting standards. Epilepsia 39(10):1088–1097CrossRefPubMed Cochrane HC, Marson AG, Baker GA, Chadwick DW (1998) Neuropsychological outcomes in randomized controlled trials of antiepileptic drugs: a systematic review of methodology and reporting standards. Epilepsia 39(10):1088–1097CrossRefPubMed
22.
Zurück zum Zitat Baker GA, Marson AG (2001) Cognitive and behavioural assessments in clinical trials: what type of measure? Epilepsy Res 45(1–3):163–167 (discussion 169–170) CrossRefPubMed Baker GA, Marson AG (2001) Cognitive and behavioural assessments in clinical trials: what type of measure? Epilepsy Res 45(1–3):163–167 (discussion 169–170) CrossRefPubMed
23.
Zurück zum Zitat Ijff DM, Aldenkamp AP (2013) Cognitive side-effects of antiepileptic drugs in children. Handb Clin Neurol 111:707–718CrossRefPubMed Ijff DM, Aldenkamp AP (2013) Cognitive side-effects of antiepileptic drugs in children. Handb Clin Neurol 111:707–718CrossRefPubMed
24.
Zurück zum Zitat Chen YJ, Kang WM, So WC (1996) Comparison of antiepileptic drugs on cognitive function in newly diagnosed epileptic children: a psychometric and neurophysiological study. Epilepsia 37(1):81–86CrossRefPubMed Chen YJ, Kang WM, So WC (1996) Comparison of antiepileptic drugs on cognitive function in newly diagnosed epileptic children: a psychometric and neurophysiological study. Epilepsia 37(1):81–86CrossRefPubMed
25.
Zurück zum Zitat Farwell J, Lee Y, Hirtz D, Sulzbacher S, Ellenberg J, Nelson K (1990) Phenobarbital for febrile seizures—Effects on intelligence and on seizure recurrence. N Engl J Med 322(6):364–369CrossRefPubMed Farwell J, Lee Y, Hirtz D, Sulzbacher S, Ellenberg J, Nelson K (1990) Phenobarbital for febrile seizures—Effects on intelligence and on seizure recurrence. N Engl J Med 322(6):364–369CrossRefPubMed
26.
Zurück zum Zitat Camfield CS, Chaplin S, Doyle AB, Shapiro SH, Cummings C, Camfield PR (1979) Side effects of phenobarbital in toddlers; behavioral and cognitive aspects. J Pediatr 95(3):361–365CrossRefPubMed Camfield CS, Chaplin S, Doyle AB, Shapiro SH, Cummings C, Camfield PR (1979) Side effects of phenobarbital in toddlers; behavioral and cognitive aspects. J Pediatr 95(3):361–365CrossRefPubMed
27.
Zurück zum Zitat Aldenkamp A, Vigevano F, Arzimanoglou A, Covanis A (2006) Role of valproate across the ages. Treatment of epilepsy in children. Acta Neurol Scand Suppl 184:1–13CrossRefPubMed Aldenkamp A, Vigevano F, Arzimanoglou A, Covanis A (2006) Role of valproate across the ages. Treatment of epilepsy in children. Acta Neurol Scand Suppl 184:1–13CrossRefPubMed
28.
Zurück zum Zitat Husain SB, Wical BS (1998) Adverse behavioral effects of valproate therapy in children with complex partial seizures. Epilepsia 39(Suppl 6):1–254 Husain SB, Wical BS (1998) Adverse behavioral effects of valproate therapy in children with complex partial seizures. Epilepsia 39(Suppl 6):1–254
29.
Zurück zum Zitat Glauser TA, Cnaan A, Shinnar S, Hirtz DG, Dlugos D, Masur D, Clark PO, Adamson PC (2013) Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months. Epilepsia 54(1):141–155CrossRefPubMed Glauser TA, Cnaan A, Shinnar S, Hirtz DG, Dlugos D, Masur D, Clark PO, Adamson PC (2013) Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months. Epilepsia 54(1):141–155CrossRefPubMed
30.
Zurück zum Zitat Masur D, Shinnar S, Cnaan A, Shinnar RC, Clark P, Wang J, Weiss EF, Hirtz DG, Glauser TA (2013) Pretreatment cognitive deficits and treatment effects on attention in childhood absence epilepsy. Neurology 81(18):1572–1580CrossRefPubMedCentralPubMed Masur D, Shinnar S, Cnaan A, Shinnar RC, Clark P, Wang J, Weiss EF, Hirtz DG, Glauser TA (2013) Pretreatment cognitive deficits and treatment effects on attention in childhood absence epilepsy. Neurology 81(18):1572–1580CrossRefPubMedCentralPubMed
31.
Zurück zum Zitat Nicolai J, Aldenkamp AP, Huizenga JR, Teune LK, Brouwer OF (2007) Cognitive side effects of valproic acid-induced hyperammonemia in children with epilepsy. J Clin Psychopharmacol 27(2):221–224CrossRefPubMed Nicolai J, Aldenkamp AP, Huizenga JR, Teune LK, Brouwer OF (2007) Cognitive side effects of valproic acid-induced hyperammonemia in children with epilepsy. J Clin Psychopharmacol 27(2):221–224CrossRefPubMed
32.
Zurück zum Zitat Eun S-H, Eun B-L, Lee JS, Hwang YS, Kim KJ, Lee Y-M, Lee IG, Lee M, Ko T-S, Kim JT, Eom S, Kim HD (2012) Effects of lamotrigine on cognition and behavior compared to carbamazepine as monotherapy for children with partial epilepsy. Brain Dev 34(10):818–823CrossRefPubMed Eun S-H, Eun B-L, Lee JS, Hwang YS, Kim KJ, Lee Y-M, Lee IG, Lee M, Ko T-S, Kim JT, Eom S, Kim HD (2012) Effects of lamotrigine on cognition and behavior compared to carbamazepine as monotherapy for children with partial epilepsy. Brain Dev 34(10):818–823CrossRefPubMed
33.
Zurück zum Zitat Eun SH, Kim HD, Chung HJ, Kang HC, Lee JS, Kim JS, You SJ, Moon HK, Lee YM, Kim DW, Suh ES, Kim JY, Lee J, Eun BL (2012) A multicenter trial of oxcarbazepine oral suspension monotherapy in children newly diagnosed with partial seizures: a clinical and cognitive evaluation. Seizure 21(9):679–684CrossRefPubMed Eun SH, Kim HD, Chung HJ, Kang HC, Lee JS, Kim JS, You SJ, Moon HK, Lee YM, Kim DW, Suh ES, Kim JY, Lee J, Eun BL (2012) A multicenter trial of oxcarbazepine oral suspension monotherapy in children newly diagnosed with partial seizures: a clinical and cognitive evaluation. Seizure 21(9):679–684CrossRefPubMed
34.
Zurück zum Zitat Brodie MJ, Sills GJ (2011) Combining antiepileptic drugs—rational polytherapy? Seizure 20(5):369–375CrossRefPubMed Brodie MJ, Sills GJ (2011) Combining antiepileptic drugs—rational polytherapy? Seizure 20(5):369–375CrossRefPubMed
35.
Zurück zum Zitat Donati F, Gobbi G, Campistol J, Rapatz G, Daehler M, Sturm Y, Aldenkamp AP (2007) The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures. Seizure 16(8):670–679CrossRefPubMed Donati F, Gobbi G, Campistol J, Rapatz G, Daehler M, Sturm Y, Aldenkamp AP (2007) The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures. Seizure 16(8):670–679CrossRefPubMed
36.
Zurück zum Zitat Curran HV, Java R (1993) Memory and psychomotor effects of oxcarbazepine in healthy human volunteers. Eur J Clin Pharmacol 44(6):529–533CrossRefPubMed Curran HV, Java R (1993) Memory and psychomotor effects of oxcarbazepine in healthy human volunteers. Eur J Clin Pharmacol 44(6):529–533CrossRefPubMed
37.
Zurück zum Zitat Pressler RM, Binnie CD, Coleshill SG, Chorley GA, Robinson RO (2006) Effect of lamotrigine on cognition in children with epilepsy. Neurology 66(10):1495–1499CrossRefPubMed Pressler RM, Binnie CD, Coleshill SG, Chorley GA, Robinson RO (2006) Effect of lamotrigine on cognition in children with epilepsy. Neurology 66(10):1495–1499CrossRefPubMed
38.
Zurück zum Zitat Brodbeck V, Jansen V, Fietzek U, Muehe C, Weber G, Heinen F (2006) Long-term profile of lamotrigine in 119 children with epilepsy. Eur J Paediatr Neurol 10(3):135–141CrossRefPubMed Brodbeck V, Jansen V, Fietzek U, Muehe C, Weber G, Heinen F (2006) Long-term profile of lamotrigine in 119 children with epilepsy. Eur J Paediatr Neurol 10(3):135–141CrossRefPubMed
39.
Zurück zum Zitat Eun SH, Kim HD, Eun BL, Lee IK, Chung HJ, Kim JS, Kang HC, Lee YM, Suh ES, Kim DW, Eom S, Lee JS, Moon HK (2011) Comparative trial of low- and high-dose zonisamide as monotherapy for childhood epilepsy. Seizure 20(7):558–563CrossRefPubMed Eun SH, Kim HD, Eun BL, Lee IK, Chung HJ, Kim JS, Kang HC, Lee YM, Suh ES, Kim DW, Eom S, Lee JS, Moon HK (2011) Comparative trial of low- and high-dose zonisamide as monotherapy for childhood epilepsy. Seizure 20(7):558–563CrossRefPubMed
40.
Zurück zum Zitat Kothare SV, Kaleyias J, Mostofi N, Valencia I, Melvin JJ, Hobdell E, Khurana DS, Legido A (2006) Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy. Pediatr Neurol 34(5):351–354CrossRefPubMed Kothare SV, Kaleyias J, Mostofi N, Valencia I, Melvin JJ, Hobdell E, Khurana DS, Legido A (2006) Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy. Pediatr Neurol 34(5):351–354CrossRefPubMed
41.
Zurück zum Zitat Malerba A, Ciampa C, De Fazio S, Fattore C, Frassine B, La Neve A, Pellacani S, Specchio LM, Tiberti A, Tinuper P, Perucca E (2010) Patterns of prescription of antiepileptic drugs in patients with refractory epilepsy at tertiary referral centres in Italy. Epilepsy Res 91(2–3):273–282CrossRefPubMed Malerba A, Ciampa C, De Fazio S, Fattore C, Frassine B, La Neve A, Pellacani S, Specchio LM, Tiberti A, Tinuper P, Perucca E (2010) Patterns of prescription of antiepileptic drugs in patients with refractory epilepsy at tertiary referral centres in Italy. Epilepsy Res 91(2–3):273–282CrossRefPubMed
42.
Zurück zum Zitat Brandl U, Kurlemann G, Neubauer B, Rettig K, Schauble B, Schreiner A (2010) Seizure and cognitive outcomes in children and adolescents with epilepsy treated with topiramate. Neuropediatrics 41(3):113–120CrossRefPubMed Brandl U, Kurlemann G, Neubauer B, Rettig K, Schauble B, Schreiner A (2010) Seizure and cognitive outcomes in children and adolescents with epilepsy treated with topiramate. Neuropediatrics 41(3):113–120CrossRefPubMed
43.
Zurück zum Zitat Coppola G, Verrotti A, Resicato G, Ferrarelli S, Auricchio G, Operto FF, Pascotto A (2008) Topiramate in children and adolescents with epilepsy and mental retardation: a prospective study on behavior and cognitive effects. Epilepsy Behav 12(2):253–256CrossRefPubMed Coppola G, Verrotti A, Resicato G, Ferrarelli S, Auricchio G, Operto FF, Pascotto A (2008) Topiramate in children and adolescents with epilepsy and mental retardation: a prospective study on behavior and cognitive effects. Epilepsy Behav 12(2):253–256CrossRefPubMed
44.
Zurück zum Zitat Moreland EC, Griesemer DA, Holden KR (1999) Topiramate for intractable childhood epilepsy. Seizure 8(1):38–40CrossRefPubMed Moreland EC, Griesemer DA, Holden KR (1999) Topiramate for intractable childhood epilepsy. Seizure 8(1):38–40CrossRefPubMed
45.
Zurück zum Zitat Ritter F, Glauser TA, Elterman RD, Wyllie E, Topiramate YP Study Group (2000) Effectiveness, tolerability, and safety of topiramate in children with partial-onset seizures. Epilepsia 41(Suppl. 1):S82–S85CrossRefPubMed Ritter F, Glauser TA, Elterman RD, Wyllie E, Topiramate YP Study Group (2000) Effectiveness, tolerability, and safety of topiramate in children with partial-onset seizures. Epilepsia 41(Suppl. 1):S82–S85CrossRefPubMed
46.
Zurück zum Zitat Kang HC, Eun BL, Wu Lee C, Ku Moon H, Kim JS, Wook Kim D, Soo Lee J, Young Chae K, Ho Cha B, Sook Suh E, Chae Park J, Lim K, Hye Ha E, Ho Song D, Dong Kim H (2007) The effects on cognitive function and behavioral problems of topiramate compared to carbamazepine as monotherapy for children with benign rolandic epilepsy. Epilepsia 48(9):1716–1723CrossRefPubMed Kang HC, Eun BL, Wu Lee C, Ku Moon H, Kim JS, Wook Kim D, Soo Lee J, Young Chae K, Ho Cha B, Sook Suh E, Chae Park J, Lim K, Hye Ha E, Ho Song D, Dong Kim H (2007) The effects on cognitive function and behavioral problems of topiramate compared to carbamazepine as monotherapy for children with benign rolandic epilepsy. Epilepsia 48(9):1716–1723CrossRefPubMed
47.
Zurück zum Zitat Halma E, de Louw AJ, Klinkenberg S, Aldenkamp AP, IJff DM, Majoie M (2014) Behavioral side-effects of levetiracetam in children with epilepsy: a systematic review. Seizure 23(9):685–691CrossRefPubMed Halma E, de Louw AJ, Klinkenberg S, Aldenkamp AP, IJff DM, Majoie M (2014) Behavioral side-effects of levetiracetam in children with epilepsy: a systematic review. Seizure 23(9):685–691CrossRefPubMed
48.
Zurück zum Zitat de la Loge C, Hunter S, Schiemann J, Yang H (2010) Assessment of behavioral and emotional functioning using standardized instruments in children and adolescents with partial-onset seizures treated with adjunctive levetiracetam in a randomized, placebo-controlled trial. Epilepsy Behav 18(3):291–298CrossRefPubMed de la Loge C, Hunter S, Schiemann J, Yang H (2010) Assessment of behavioral and emotional functioning using standardized instruments in children and adolescents with partial-onset seizures treated with adjunctive levetiracetam in a randomized, placebo-controlled trial. Epilepsy Behav 18(3):291–298CrossRefPubMed
49.
Zurück zum Zitat Levisohn P, Mintz M, Hunter S, Yang H, Jones J, on behalf of the N01103 Levetiracetam Study Group (2009) Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomised, double-blind, placebo-controlled, noninferiority trial. Epilepsia 50(11):2377–2389CrossRefPubMed Levisohn P, Mintz M, Hunter S, Yang H, Jones J, on behalf of the N01103 Levetiracetam Study Group (2009) Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomised, double-blind, placebo-controlled, noninferiority trial. Epilepsia 50(11):2377–2389CrossRefPubMed
50.
Zurück zum Zitat Achenbach TM (1999) The use of psychological testing for treatment planning and outcomes assessment, 2nd edn. Lawrence Erlbaum Associates Publishers, Mahwah Achenbach TM (1999) The use of psychological testing for treatment planning and outcomes assessment, 2nd edn. Lawrence Erlbaum Associates Publishers, Mahwah
51.
Zurück zum Zitat Schiemann-Delgado J, Yang H, Loge Cde L, Stalvey TJ, Jones J, Legoff D, Mintz M (2012) A long-term open-label extension study assessing cognition and behavior, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16 years with partial-onset seizures. J Child Neurol 27(1):80–89CrossRefPubMed Schiemann-Delgado J, Yang H, Loge Cde L, Stalvey TJ, Jones J, Legoff D, Mintz M (2012) A long-term open-label extension study assessing cognition and behavior, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16 years with partial-onset seizures. J Child Neurol 27(1):80–89CrossRefPubMed
52.
Zurück zum Zitat Posar A, Salerno GG, Monti M, Santucci M, Scaduto MC, Parmeggiani A (2014) Neuropsychological implications of adjunctive levetiracetam in childhood epilepsy. J Pediatr Neurosci 9(2):115–120CrossRefPubMedCentralPubMed Posar A, Salerno GG, Monti M, Santucci M, Scaduto MC, Parmeggiani A (2014) Neuropsychological implications of adjunctive levetiracetam in childhood epilepsy. J Pediatr Neurosci 9(2):115–120CrossRefPubMedCentralPubMed
54.
Zurück zum Zitat Lagae L, Velkey I, Bagul M, Yang H, Laurenza A, Kumar D (2014) Impact of adjunctive perampanel on behaviour in adoloscents with refractory partial-onset seizures. Epilepsia 55(Suppl 2):4–246 (abstract p558 and poster presented at ECE 2014) Lagae L, Velkey I, Bagul M, Yang H, Laurenza A, Kumar D (2014) Impact of adjunctive perampanel on behaviour in adoloscents with refractory partial-onset seizures. Epilepsia 55(Suppl 2):4–246 (abstract p558 and poster presented at ECE 2014)
55.
Zurück zum Zitat Wesnes KA (2005) An automated system for assessing cognitive function in any environment. SPIE Congress:Abstract 5797, Biomonitoring for Physiological and Cognitive Performance during Military Operations, 5724 (May 5723, 2005) Wesnes KA (2005) An automated system for assessing cognitive function in any environment. SPIE Congress:Abstract 5797, Biomonitoring for Physiological and Cognitive Performance during Military Operations, 5724 (May 5723, 2005)
56.
Zurück zum Zitat Wesnes KA, Edgar C, Dean ADP, Wroe SJ (2009) The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy. Epilepsy Behav 14(3):522–528CrossRefPubMed Wesnes KA, Edgar C, Dean ADP, Wroe SJ (2009) The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy. Epilepsy Behav 14(3):522–528CrossRefPubMed
57.
Zurück zum Zitat Parada J, Czuczwar SJ, Turski WA (1992) NBQX does not affect learning and memory tasks in mice: a comparison with D-CPPene and ifenprodil. Brain Res Cogn Brain Res 1(1):67–71CrossRefPubMed Parada J, Czuczwar SJ, Turski WA (1992) NBQX does not affect learning and memory tasks in mice: a comparison with D-CPPene and ifenprodil. Brain Res Cogn Brain Res 1(1):67–71CrossRefPubMed
58.
Zurück zum Zitat Pitsikas N, Rigamonti AE, Cella SG, Muller EE (2002) The non-NMDA receptor antagonist NBQX does not affect rats performance in the object recognition task. Pharmacol Res 45(1):43–46CrossRefPubMed Pitsikas N, Rigamonti AE, Cella SG, Muller EE (2002) The non-NMDA receptor antagonist NBQX does not affect rats performance in the object recognition task. Pharmacol Res 45(1):43–46CrossRefPubMed
Metadaten
Titel
The importance of assessing behaviour and cognition in antiepileptic drug trials in children and adolescents
verfasst von
Lieven Lagae
Publikationsdatum
20.12.2016
Verlag
Springer International Publishing
Erschienen in
Acta Neurologica Belgica / Ausgabe 2/2017
Print ISSN: 0300-9009
Elektronische ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-016-0734-y

Weitere Artikel der Ausgabe 2/2017

Acta Neurologica Belgica 2/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Neu im Fachgebiet Neurologie

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.